Microsoft president Brad Smith: As an American technology company, we can do business in China only when ...

Microsoft president Brad Smith: As an American technology company, we can do business in China only when …

Microsoft Vice Chair and President Brad Smith speaks at the Web Summit, in Lisbon, Portugal, November 12, 2024. REUTERS/Pedro Nunes Microsoft‘s president and vice-chairman, Brad Smith, cautioned the West against assuming China is lagging behind in technological development. Speaking recentky at the Web Summit tech conference in Lisbon, Portugal, Smith told CNBC that China is…

Read More
Trump rally could bring about 'new uncertainty' as markets calm

Trump rally could bring about ‘new uncertainty’ as markets calm

Donald Trump’s reelection resulted in serious gains across markets and particular sectors in Wednesday’s trading session. Investors saw the Trump Trade turn into a “Trump Everything Rally,” Powers Advisory Group Managing Partner Matt Powers tells Yahoo Finance, noting the spark seen in the financial (XLF) and utilities (XLU) sectors. Powers sits down with Brad Smith…

Read More
US housing affordability, November's market seasonality: Wealth

US housing affordability, November’s market seasonality: Wealth

In today’s installment of Wealth, Brad Smith tackles the biggest personal finance topics ahead of Tuesday’s presidential election. The show welcomes Haywood Wealth Management president and co-founder Justin Haywood to discuss how investors should interpret market volatility connected to the 2024 election and the Federal Reserve’s interest rate decision this week. Romer Debbas managing partner…

Read More
Bristol Myers Squibb stock rises, Merck moves lower. Here's why.

Bristol Myers Squibb stock rises, Merck moves lower. Here’s why.

Pharmaceutical giant Bristol Myers Squibb (BMY) raises its full-year earnings guidance after topping third quarter estimates, sending shares higher in pre-market trading. Concurrently, Merck & Co. (MRK) lowered its sales outlook despite topping third quarter estimates, sending the stock lower. Julie Hyman and Brad Smith report more on these two pharma companies’ earnings results tied…

Read More